TTM
81.8%
YoY change
−3.69pp
Trough year (1986)
21.3%
Peak year (2015)
85.0%
Latest annual
81.0%
Gross Margin history chart for Novo Nordisk (NVO) from 1985 to 2025
Latest: 81.0%
Gross Margin change chart for Novo Nordisk (NVO) from 1985 to 2025
Latest: −3.69pp
Gross Margin history table for Novo Nordisk (NVO) from 1985 to 2025
| 2025 | 81.0% | -3.69pp | ||
| 2024 | 84.7% | +0.07pp | ||
| 2023 | 84.6% | +0.68pp | ||
| 2022 | 83.9% | +0.73pp | ||
| 2021 | 83.2% | -0.31pp | ||
| 2020 | 83.5% | -0.03pp | ||
| 2019 | 83.5% | -0.71pp | ||
| 2018 | 84.2% | +0.03pp | ||
| 2017 | 84.2% | -0.41pp | ||
| 2016 | 84.6% | -0.37pp | ||
| 2015 | 85.0% | +1.40pp | ||
| 2014 | 83.6% | +0.52pp | ||
| 2013 | 83.1% | +0.34pp | ||
| 2012 | 82.7% | +1.72pp | ||
| 2011 | 81.0% | +0.24pp | ||
| 2010 | 80.8% | +1.22pp | ||
| 2009 | 79.6% | +1.75pp | ||
| 2008 | 77.8% | +1.22pp | ||
| 2007 | 76.6% | +1.34pp | ||
| 2006 | 75.3% | +2.44pp | ||
| 2005 | 72.8% | +0.54pp | ||
| 2004 | 72.3% | +0.31pp | ||
| 2003 | 72.0% | -1.70pp | ||
| 2002 | 73.7% | -1.19pp | ||
| 2001 | 74.9% | -4.11pp | ||
| 2000 | 79.0% | +1.04pp | ||
| 1999 | 77.9% | +1.49pp | ||
| 1998 | 76.4% | +4.24pp | ||
| 1997 | 72.2% | +0.16pp | ||
| 1996 | 72.0% | -0.04pp | ||
| 1995 | 72.1% | +0.43pp | ||
| 1994 | 71.6% | +20.39pp | ||
| 1993 | 51.3% | -25.07pp | ||
| 1992 | 76.3% | +25.11pp | ||
| 1991 | 51.2% | +0.73pp | ||
| 1990 | 50.5% | -0.10pp | ||
| 1989 | 50.6% | -1.16pp | ||
| 1988 | 51.7% | +3.26pp | ||
| 1987 | 48.5% | +27.15pp | ||
| 1986 | 21.3% | -28.80pp | ||
| 1985 | 50.1% | — |
- 202581.0%-3.69pp
- 202484.7%+0.07pp
- 202384.6%+0.68pp
- 202283.9%+0.73pp
- 202183.2%-0.31pp
- 202083.5%-0.03pp
- 201983.5%-0.71pp
- 201884.2%+0.03pp
- 201784.2%-0.41pp
- 201684.6%-0.37pp
- 201585.0%+1.40pp
- 201483.6%+0.52pp
- 201383.1%+0.34pp
- 201282.7%+1.72pp
- 201181.0%+0.24pp
- 201080.8%+1.22pp
- 200979.6%+1.75pp
- 200877.8%+1.22pp
- 200776.6%+1.34pp
- 200675.3%+2.44pp
- 200572.8%+0.54pp
- 200472.3%+0.31pp
- 200372.0%-1.70pp
- 200273.7%-1.19pp
- 200174.9%-4.11pp
- 200079.0%+1.04pp
- 199977.9%+1.49pp
- 199876.4%+4.24pp
- 199772.2%+0.16pp
- 199672.0%-0.04pp
- 199572.1%+0.43pp
- 199471.6%+20.39pp
- 199351.3%-25.07pp
- 199276.3%+25.11pp
- 199151.2%+0.73pp
- 199050.5%-0.10pp
- 198950.6%-1.16pp
- 198851.7%+3.26pp
- 198748.5%+27.15pp
- 198621.3%-28.80pp
- 198550.1%—
Gross Margin values are taken from Novo Nordisk's reported income statements (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in DKK as filed.
About Gross Margin at Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's latest reported gross margin is 81.8%. Gross margin is gross profit divided by revenue, expressed as a percentage. It shows how much of each sales dollar survives the direct cost of goods sold — before operating expenses, interest, and taxes. A higher gross margin generally signals pricing power and production efficiency. Margins are most meaningful compared against sector peers and a company's own history.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Novo Nordisk (NVO) gross margin is 80.98% – contracted 3.7 percentage points year-over-year.
The record annual gross margin stands at 85.00%, reached in 2015; the historical low of 21.34% was recorded in 1986.
Novo Nordisk Gross Margin by Year
Novo Nordisk Gross Margin 2025: 81.0%
Novo Nordisk gross margin in 2025 was 80.98%, contracted 3.7 percentage points from 2024.
Novo Nordisk Gross Margin 2024: 84.7%
2024's gross margin for Novo Nordisk came in at 84.67%, expanded 0.1 percentage points from 2023.
Novo Nordisk Gross Margin 2023: 84.6%
Novo Nordisk posted gross margin of 84.60% in 2023, expanded 0.7 percentage points from 2022.
Novo Nordisk Gross Margin 2022: 83.9%
In 2022, Novo Nordisk reported gross margin of 83.92%, expanded 0.7 percentage points from 2021.
Novo Nordisk Gross Margin 2021: 83.2%
Novo Nordisk gross margin in 2021 was 83.20%.
See more financial history for Novo Nordisk (NVO).
Sector peers by Gross Margin
Healthcare peers of Novo Nordisk (NVO), ranked by their latest gross margin
| 83.5% | |
| 81.7% | |
| 75.9% | |
| 71.5% | |
| 70.7% | |
| 70.0% | |
| 39.4% | |
| 18.8% |
- 83.5%
- 81.7%
- 75.9%
- 71.5%
- 70.7%
Frequently asked questions
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation